Abstract
This report describes the first heart transplantation recipient with acute biventricular heart failure symptoms caused by a post-myocarditis state, late after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. No other viral pathogens could be detected. Computed tomography angiography did not show cardiac allograft vasculopathy, and myocardial biopsy demonstrated no clinically relevant rejection. Subsequent cardiovascular magnetic resonance imaging revealed extensive epicardial delayed enhancement without myocardial edema. Heart failure medication was initiated and an implantable cardioverter defibrillator was implanted (due to non-sustained ventricular tachycardias), leading to a partial recovery of the ejection fraction. Further studies are needed to investigate the number of heart transplant recipients with myocardial damage after a SARS-CoV-2 infection.
Keywords: Acute heart failure; COVID-19; Heart transplantation; Magnetic resonance imaging.
【저자키워드】 COVID-19, magnetic resonance imaging, Acute heart failure, Heart transplantation, 【초록키워드】 SARS-CoV-2, coronavirus, magnetic resonance imaging, SARS-COV-2 infection, Infection, tomography, Symptom, severe acute respiratory syndrome Coronavirus, heart failure, Computed tomography, Acute heart failure, myocarditis, myocardial damage, heart, edema, Heart transplantation, Pathogens, medication, acute respiratory syndrome, Ejection fraction, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, viral pathogen, recipient, rejection, Myocardial, implantable cardioverter defibrillator, caused, clinically, demonstrated, initiated, cardiac allograft, ventricular,